| Revenue growth | FY26 revenue declined 8% YoY to Rs 1,713 Cr. |
|---|---|
| Margins | Q4 EBITDA margin improved to 20.3% from 16.8% QoQ. |
| Order book | Improved order inflow uptick in crop protection segment. |
| Demand visibility | Improving customer demand and volume traction in Crop Protection. |
| Management confidence | Confident foundation in place for a stronger FY27. |
Growth
Q4 revenue grew 5% QoQ but declined 6% YoY. Pharmaceutical revenue grew 60% in H2 vs H1 FY26.
Outlook
Expects Specialty Chemicals contribution from FY27. DMF filings target increased to 5-6 annually. US FDA CAPAs nearing completion.
Risks
Exceptional impairment costs at Panoli and new labor code impact. Competitive pricing pressures in Crop Protection.
Earnings Call filed with NSE, NSE: HIKAL. Summary written with AI assistance from the document.
Hikal Ltd: key numbers
- Share price
- ₹226.43
- Market cap
- ₹2,792 Cr
- Revenue (annual)
- ₹1,713 Cr
- Net profit (annual)
- ₹-48.80 Cr
- P/E (TTM)
- -82.6×Sector 47.4×
- Promoter holding
- 68.85%+0.00% QoQ
- FII holding
- 0.98%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Hikal Ltd
All →Hikal Annual General Meeting
Hikal Ltd held its 38th AGM on September 23, 2026, approving financial statements, director appointments, remuneration revisions, and declaring a total dividend of ₹0.60 per share.
Hikal Production Started
Hikal has begun commercial production at its new cGMP Panoli facility, entering Personal Care manufacturing. First batches of UV filters and skincare ingredients are now being supplied to global customers.
Hikal Other Announcement
Hikal Ltd has filed its Business Responsibility and Sustainability Report for FY 2025-26, fulfilling regulatory compliance requirements under SEBI (LODR) Regulations, 2015.
Hikal Annual Report
Hikal Limited has submitted its Annual Report for FY 2025-26 and the Notice of its 38th Annual General Meeting to the stock exchanges.
Hikal Annual General Meeting
Hikal Ltd has scheduled its 38th Annual General Meeting for September 23, 2026. The company fixed September 04, 2026, as the record date for final dividend eligibility.
Hikal Management Change
Hikal Limited has appointed Mr. Sameer Hiremath as Chairman and Managing Director for five years. The appointment is effective from October 1, 2026, subject to shareholder approval.
- Execution
- 5 years